The risk of tuberculosis was significantly increased by TNF inhibitors (incidence rate ratio = 3.61 with a 95% CI 1.38–8.07 for patients with RA and incidence rate ratio = 4.87 with a 95% CI 1.50–15.39 for patients with AS) [101]. This evidence concerns the gene TNF and tuberculosis.